Northwire Canada EditionThursday, July 16, 2026
Northwire
NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8% CAM 0.330 −1.5% NTR 94.27 −1.8% LALI 0.055 −8.3% SCD 0.170 +0.0% HWY 0.370 +0.0% FCI 0.385 +1.3% GGAU 0.180 −5.3% KIRO 0.650 +1.6% LBNK 0.430 +0.0% BARU 0.040 +0.0% VCU 1.09 −4.4% NOBL 0.095 −5.0% SHL 0.355 +0.0% MTS 0.130 +0.0% FYL 0.090 +0.0% NUAG 5.55 +1.8% CAM 0.330 −1.5%
Financings

Bausch Health Announces Early Exchange Offer Results for Exchange Offers

BHC · Price

Executive Summary

  • Bausch Health reported that holders have tendered $2.69 billion of its existing 4.875% and 11.00% senior secured notes, exceeding the amount needed to trigger the exchange.
  • Based on proration rules, the company expects to issue approximately $1.6 billion of new 10.00% senior secured notes due 2032.
  • The withdrawal period closed at 5:00 p.m. NY time on Dec 8, and the offer will expire at 5:00 p.m. NY time on Dec 23, 2025.

Key Details

  • Existing Notes Tendered (as of early tender deadline):
  • 11.00% Senior Secured Notes due 2028 – $1,519,477,000 tendered (out of $1,774,067,000 outstanding).
  • 4.875% Senior Secured Notes due 2028 – $1,170,539,000 tendered (out of $1,600,000,000 outstanding).

  • Total Principal Tendered: $2,690,016,000.

  • Maximum New Notes Amount: $1.6 billion aggregate principal.

  • Expected Issuance of New Notes: Approximately $1.6 billion of 10.00% Senior Secured Notes due 2032, subject to proration and other conditions in the Exchange Offer Memorandum.

  • Key Dates:

  • Withdrawal deadline – 5:00 p.m., NY time, Dec 8, 2025 (no extensions).
  • Offer expiration – 5:00 p.m., NY time, Dec 23, 2025 (or later if extended at the Offerors’ discretion).
  • Settlement expected within three business days after expiration, or as promptly as practicable.

  • Eligibility: Offers limited to qualified institutional buyers/qualified purchasers in the U.S. and non‑U.S. persons complying with Regulation S; Canadian holders must submit a specific holder form.

  • Exchange Agent / Information Agent: D.F. King & Co., Inc.; contact numbers provided for banks/brokers and general inquiries.

  • No Recommendation Disclaimer: Offerors, affiliates, officers, directors, agents, and trustees make no recommendation regarding participation.

Notable Quotes

(None included in the release.)

Read the original news release →

More from BAUSCH HEALTH COMPANIES INC.